DEVELOPMENT OF A FORMULATION OF SUSTAINED-RELEASE POTASSIUM-CHLORIDE

被引:0
|
作者
PEZOA, R [1 ]
JOPIA, O [1 ]
MONARDES, AM [1 ]
ARANCIBIA, A [1 ]
机构
[1] UNIV CHILE,DEPT CIENCIAS & TECNOL FARMACEUT,SANTIAGO,CHILE
关键词
D O I
10.3109/03639049109074398
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this work has been the designing and "in vitro" evaluation of a potassium chloride tablet using a wax matrix. Carnauba wax, stearyl alcohol and stearic acid were employed to prepare granulates at different drug/wax ratios. From dissolution kinetic studies and technological performances a 75/25 - KCl/carnauba wax granulates was selected. The rheological properties of granulates were characterized and tablets were manufactured employing commun tablets excipients. Also a coating procedure was developed. The coated tablet formulation selected release the potassium chloride according to the USP requirements. The dissolution kinetics of the potassium chloride from both coated and uncoated tablets fit the Higuchi diffusion model, giving a straight line when the amount dissolved is plotted against the square root of time.
引用
收藏
页码:1875 / 1882
页数:8
相关论文
共 50 条
  • [11] DEVELOPMENT AND PHARMACOKINETICS OF A NEW SUSTAINED-RELEASE FORMULATION OF DILTIAZEM
    THIERCELIN, JF
    NECCIARI, J
    CAPLAIN, H
    COURNOT, A
    COMBES, M
    DESMOLIN, H
    FLOUVAT, B
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 : S31 - S37
  • [12] FORMULATION OF TABLETS WITH SUSTAINED-RELEASE
    SALOMON, JL
    DOELKER, E
    PHARMACEUTICA ACTA HELVETIAE, 1980, 55 (06): : 174 - 182
  • [13] POISONING WITH SUSTAINED-RELEASE POTASSIUM
    STEEDMAN, DJ
    ARCHIVES OF EMERGENCY MEDICINE, 1988, 5 (04): : 206 - 211
  • [14] Enhanced Elimination in Sustained-release Potassium Chloride Poisoning - A Case Series
    Gunja, N.
    CLINICAL TOXICOLOGY, 2010, 48 (03) : 247 - 247
  • [15] SLOW RELEASE POTASSIUM-CHLORIDE TREATMENT
    HOWIE, AD
    STRACHAN, RW
    BRITISH MEDICAL JOURNAL, 1975, 2 (5964): : 176 - 176
  • [16] DEVELOPMENT AND INVITRO EVALUATION OF A MULTIPARTICULATE SUSTAINED-RELEASE THEOPHYLLINE FORMULATION
    YUEN, KH
    DESHMUKH, AA
    NEWTON, JM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (08) : 855 - 874
  • [17] Development of a sustained-release recombinant human growth hormone formulation
    Kwak, H. H.
    Shim, W. S.
    Choi, M. K.
    Son, M. K.
    Kim, Y. J.
    Yang, H. C.
    Kim, T. H.
    Lee, G. I.
    Kim, B. M.
    Kang, S. H.
    Shim, C. K.
    JOURNAL OF CONTROLLED RELEASE, 2009, 137 (02) : 160 - 165
  • [18] A research on aspirin sustained-release formulation
    Xu, GJ
    Fang, F
    Zhang, RH
    Sunada, H
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (08) : 741 - 747
  • [19] Sustained-release formulation of sarpogrelate hydrochloride
    Hye Jin Kim
    Dae Hwan Shin
    Eun Ah Lim
    Jin-Seok Kim
    Archives of Pharmacal Research, 2015, 38 : 35 - 41
  • [20] SUSTAINED-RELEASE FORMULATION OF SALBUTAMOL SULFATE
    MURTHY, RSR
    MALHOTRA, M
    MIGLANI, BD
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (10) : 1373 - 1380